-
1
-
-
0034729996
-
Efficacy and harm of pharmacological prevention of acute mountain sickness: Quantitative systematic review
-
L. Dumont, C. Mardirosoff, M.R. Tramer Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review BMJ 321 2000 267 272 (Pubitemid 30487464)
-
(2000)
British Medical Journal
, vol.321
, Issue.7256
, pp. 267-272
-
-
Dumont, L.1
Mardirosoff, C.2
Tramer, M.R.3
-
3
-
-
0017109687
-
The incidence, importance, and prophylaxis of acute mountain sickness
-
P.H. Hackett, D. Rennie, H.D. Levine The incidence, importance, and prophylaxis of acute mountain sickness Lancet 2 1976 1149 1155
-
(1976)
Lancet
, vol.2
, pp. 1149-1155
-
-
Hackett, P.H.1
Rennie, D.2
Levine, H.D.3
-
5
-
-
84866732628
-
-
Accessed July 15, 2011
-
Emergency Medical Abstracts http://www.emaonline.org Accessed July 15, 2011
-
Emergency Medical Abstracts
-
-
-
7
-
-
33646093759
-
Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE
-
S.S.L. Wong, N.L. Wilczynski, R.B. Haynes Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE J Med Libr Assoc 94 2006 41 47
-
(2006)
J Med Libr Assoc
, vol.94
, pp. 41-47
-
-
Wong, S.S.L.1
Wilczynski, N.L.2
Haynes, R.B.3
-
8
-
-
33745173128
-
Prevention of acute mountain sickness by acetazolamide in Nepali porters: A double-blind controlled trial
-
P. Hillenbrand, A.K. Pahari, Y. Soon et al. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial Wilderness Environ Med 17 2006 87 93 (Pubitemid 43902276)
-
(2006)
Wilderness and Environmental Medicine
, vol.17
, Issue.2
, pp. 87-93
-
-
Hillenbrand, P.1
Pahari, A.K.2
Soon, Y.3
Subedi, D.4
Bajracharya, R.5
Gurung, P.6
Lal, B.K.7
Marahatta, R.8
Pradhan, S.9
Rai, D.10
Sharma, S.11
-
9
-
-
0037367823
-
Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial
-
B. Basnyat, J.H. Gertsch, E.W. Johnson et al. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial High Alt Med Biol 4 2003 45 52 (Pubitemid 36511798)
-
(2003)
High Altitude Medicine and Biology
, vol.4
, Issue.1
, pp. 45-52
-
-
Basnyat, B.1
Gertsch, J.H.2
Johnson, E.W.3
Castro-Marin, F.4
Inoue, Y.5
Yeh, C.6
-
10
-
-
1642302117
-
Magnesium for the prevention and treatment of acute mountain sickness
-
DOI 10.1042/CS20030187
-
L. Dumont, C. Lysakowski, M.R. Tramer et al. Magnesium for the prevention and treatment of acute mountain sickness Clin Sci 106 2004 269 277 (Pubitemid 38365833)
-
(2004)
Clinical Science
, vol.106
, Issue.3
, pp. 269-277
-
-
Dumont, L.1
Lysakowski, C.2
Tramer, M.R.3
Junod, J.-D.4
Mardirosoff, C.5
Tassonyi, E.6
Kayser, B.7
-
11
-
-
0036886433
-
Glucocorticoids as prophylaxis against acute mountain sickness
-
DOI 10.1046/j.1365-2265.2002.01664.x
-
M. Basu, R.C. Sawhney, S. Kumar et al. Glucocorticoids as prophylaxis against acute mountain sickness Clin Endocrinol 57 2002 761 767 (Pubitemid 36963004)
-
(2002)
Clinical Endocrinology
, vol.57
, Issue.6
, pp. 761-767
-
-
Basu, M.1
Sawhney, R.C.2
Kumar, S.3
Pal, K.4
Prasad, R.5
Selvamurthy, W.6
-
12
-
-
77956473650
-
Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: The Headache Evaluation at Altitude Trial (HEAT)
-
J.H. Gertsch, G.S. Lipman, P.S. Holck et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT) Wilderness Environ Med 21 2010 236 243
-
(2010)
Wilderness Environ Med
, vol.21
, pp. 236-243
-
-
Gertsch, J.H.1
Lipman, G.S.2
Holck, P.S.3
-
13
-
-
79952299742
-
Spironolactone does not prevent acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group)
-
B. Basnyat, P.S. Holck, M. Pun et al. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group) Wilderness Environ Med 22 2011 15 22
-
(2011)
Wilderness Environ Med
, vol.22
, pp. 15-22
-
-
Basnyat, B.1
Holck, P.S.2
Pun, M.3
-
14
-
-
39749134862
-
Gabapentin for prevention of hypobaric hypoxia-induced headache: Randomized double-blind clinical trial
-
DOI 10.1136/jnnp.2007.124727
-
S. Jafarian, R. Abolfazli, F. Gorouhi et al. Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial J Neurol Neurosurg Psychiatry 79 2008 321 323 (Pubitemid 351303393)
-
(2008)
Journal of Neurology, Neurosurgery and Psychiatry
, vol.79
, Issue.3
, pp. 321-323
-
-
Jafarian, S.1
Abolfazli, R.2
Gorouhi, F.3
Rezaie, S.4
Lotfi, J.5
-
15
-
-
34948847615
-
Sumatriptan for prevention of acute mountain sickness: Randomized clinical trial
-
DOI 10.1002/ana.21162
-
S. Jafarian, F. Gorouhi, S. Salimi et al. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial Ann Neurol 62 2007 273 277 (Pubitemid 47525403)
-
(2007)
Annals of Neurology
, vol.62
, Issue.3
, pp. 273-277
-
-
Jafarian, S.1
Gorouhi, F.2
Salimi, S.3
Lotfi, J.4
-
16
-
-
33645651531
-
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: The Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) trial
-
B. Basnyat, J.H. Gertsch, P.S. Holck et al. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) trial High Alt Med Biol 7 2006 17 27
-
(2006)
High Alt Med Biol
, vol.7
, pp. 17-27
-
-
Basnyat, B.1
Gertsch, J.H.2
Holck, P.S.3
-
17
-
-
1842506452
-
Randomised, double blind, placebo controlled comparison of Ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: The Prevention of High Altitude Illness Trial (PHAIT)
-
J.H. Gertsch, B. Basnyat, E.W. Johnson et al. Randomised, double blind, placebo controlled comparison of Ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the Prevention of High Altitude Illness Trial (PHAIT) BMJ 328 2004 797
-
(2004)
BMJ
, vol.328
, pp. 797
-
-
Gertsch, J.H.1
Basnyat, B.2
Johnson, E.W.3
-
18
-
-
65449175766
-
Oral antioxidant supplementation does not prevent acute mountain sickness: Double blind, randomized placebo-controlled trial
-
J.K. Baillie, A.A.R. Thompson, J.B. Irving et al. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial QJM 102 2009 341 348
-
(2009)
QJM
, vol.102
, pp. 341-348
-
-
Baillie, J.K.1
Thompson, A.A.R.2
Irving, J.B.3
-
19
-
-
84859107006
-
Altitude sickness
-
D. Murdoch Altitude sickness Clin Evid 3 2010 1 11
-
(2010)
Clin Evid
, vol.3
, pp. 1-11
-
-
Murdoch, D.1
-
20
-
-
58149263352
-
Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness
-
M.C.T. van Patot, G. Leadbetter, L.E. Keyes et al. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness High Alt Med Biol 9 2008 289 293
-
(2008)
High Alt Med Biol
, vol.9
, pp. 289-293
-
-
Van Patot, M.C.T.1
Leadbetter, G.2
Keyes, L.E.3
-
21
-
-
13444300988
-
Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: A randomized, placebo-controlled trial
-
DOI 10.1001/archinte.165.3.296
-
T. Chow, V. Browne, H.L. Heileson et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial Arch Intern Med 165 2005 296 301 (Pubitemid 40216282)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.3
, pp. 296-301
-
-
Chow, T.1
Browne, V.2
Heileson, H.L.3
Wallace, D.4
Anholm, J.5
Green, S.M.6
|